At Project MADAM we have a working committee, a council consisting of various specialists, who are involved in approving our drug doses as well as an advisory board of stakeholder organisations who can provide tips regarding the strategy and sustainability of the project.
Working committee
Prof. Dr. Saskia de Wildt
Dr. Liesbeth Scheepers
Dr. Vera Bukkems
Dr. Anneke Passier
Dr. Rick Greupink
Caroline Dibbets
Dagmar Hiensch
Dr. Sam Schoenmakers
Remke Dullemond
Freke Wilmink
Dr. Robert Flint
Dr. Peter ter Horst
Jeroen Brogtrop
Dr. Simone van den Elsen
Ilona Tiemens
Prof. Dr. Mirjam van Weissenbruch
Prof. Dr. Karel Allegaert
Dr. Roos van Westrhenen
Dr. Peter Theunissen
Dr. Verna Jans
Dr. Tjitske van der Zanden
Kim Vanden Auweele
Leon Kusters
Milja de Vries
Yvonne Meijer-Pennings
Marieke Bulsink
Dr. Michael Rodgers
Dr. Victorine Roos
Dr. Bas Schouwenberg
Advisory board
Prof. Dr. Saskia de Wildt
Dr. Liesbeth Scheepers
Dr. Anneke Passier
Dr. Charlotte Koldeweij
Milja de Vries
Dr. Peter Theunissen
Jurgen Pesch
Dr. Tjitske van der Zanden
Marleen Journee-Gilissen
Minke Kranenborg
Imara Wilsens
Prof. Dr. Agnes Kant
Miranda van Tuyl
Dr. Sonno Simons
Dr. Sam Schoenmakers
Dr. Caroline Bax
Dr. Peter ter Horst
Ilse van Ee
Maaike de Wit